Genomic studies have also revealed that during metastatic progression of melanoma, metastases display genetic features that are characteristic of immune cells, not only PD-L1 (CD274) but also CTLA4 and several other genes that may be important for immune resistance, constituting a newly identified form of phenotypic plasticity, the so-called immunogenic mimicry [76]. Here, CD274 is linked to melanoma.